PAREXEL Launches Patient Innovation Center

September 11, 2018

Applied Clinical Trials

PAREXEL's Patient Innovation Center is launched to help sponsors navigate patient centricity from protocol, through study implementation and commercialization access.

PAREXEL  announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access.  With a patient-centric approach, the Center can help sponsors improve the drug development process by reducing the practical, financial and geographical barriers patients and caregivers often face, and optimize patient involvement and engagement.

PAREXEL’s Patient Innovation Center services include clinical study planning, which incorporates the company's Patient-Centric Protocol Optimization service; study implementation, which includes elements such as online recruitment, eConsent, home nursing, direct-to-patient drug shipments, patient apps and video dosing to enhance patient experience and compliance and PAREXEL’s Patient Sensor Soluition service is focused on continuous data collection through the use of wearables; and Patient and Market Access.

Read the press release here.

Related Content:

News